BUSINESSBLOOMBERG
GSK Agrees to Buy Nuvalent for $10.6 Billion
GSK has agreed to buy Nuvalent for $10.6 billion. The acquisition is valued at $10.6 billion.
Mentioned
Related Signal
Adjacent reporting
- Fertitta Entertainment agrees to buy Caesars Entertainment for $17.6 billion
- Ethereum news: Bitmine (BMNR) to buy 10,000 ETH for $23.8M from Ethereum Foundation
- Kraken Parent to Buy Reap for $600 Million
- Sitecore Said to Acquire Scrunch for $225 Million
- SpaceX says it has agreement to acquire Cursor for $60B
- Billionaire Tilman Fertitta to buy Caesars Entertainment in $17.6bn deal